There were 1,035 press releases posted in the last 24 hours and 190,187 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Biogenum Announces Favorable Safety Profile for Tau NonTangles™ in a Phase 1/2 Clinical Trial in Patients with Alzheimer

TO:
Alice Lum
Biogenum
+82 1855552863

FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image